GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Remedium Lifecare Ltd (BOM:539561) » Definitions » Research & Development

Remedium Lifecare (BOM:539561) Research & Development : ₹0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Remedium Lifecare Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Remedium Lifecare's Research & Development for the three months ended in Dec. 2024 was ₹0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0 Mil.


Remedium Lifecare Research & Development Historical Data

The historical data trend for Remedium Lifecare's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Remedium Lifecare Research & Development Chart

Remedium Lifecare Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Remedium Lifecare Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Remedium Lifecare Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Remedium Lifecare  (BOM:539561) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Remedium Lifecare Research & Development Related Terms

Thank you for viewing the detailed overview of Remedium Lifecare's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Remedium Lifecare Business Description

Traded in Other Exchanges
N/A
Address
Saugbaug Road, Office No. 9, Behind Ravi Vihar Hotel, K Raheja Prime, Marol Industrial Estate, Andheri (East), Mumbai, MH, IND, 400059
Remedium Lifecare Ltd is engaged in the business of trading in API Intermediates (KSMs & CRMs) and various other raw materials used in API trading viz. Iso propyl Alcohol (IPA), Cyclohexane, DI Iso Propyl Amine (DIPA), Ethyl Acetate, Hydrazine Hydrate, Iso propyl Alcohol (IPA), Methylene Di Chloride, Potassium Carbonate Powder, Sodium Bi-Carbonate, Potassium Hydroxide Flakes, Sodium Chloride (Common Salt), Sodium Carbonate (SODA ASH), Amino isophthalic Acid, Tellurium(IV) Oxide, Grignard Reagent, Iodine, Selenium Metal Powder, Trimethyl Sulfoxonium Iodide (TMSI).

Remedium Lifecare Headlines

No Headlines